Eton Pharmaceuticals Inc
Veridion Score
Composite trend over time
Why is ETON moving today?
Eton Pharmaceuticals Inc is a United States based specialty pharmaceutical company. The company is engaged in developing and commercializing pharmaceutical products to fulfill an unmet patient need. It has eight commercial rare disease products, INCRELEX, ALKINDI SPRINKLE, KHINDIVITM, GALZIN, PKU GOLIKE, Carglumic Acid, Betaine Anhydrous and Nitisinone. It also has five additional product candidates in late-stage development: ET-600, Amglidia, ET-700, ET-800 and ZENEO hydrocortisone autoinjector.
Real vendor fields plus Veridion-computed history. Missing fields stay blank.
Warehouse intelligence for ETON.
ETON insider activity
Eton Pharmaceuticals Inc
2 insiders bought in the last 90 days
Net selling: -$7.7M across loaded Form 4 rows.
Loaded official disclosures do not show all three sources aligned on this ticker.
| Filing date | Trade date | Insider | Title | Type | Price | Qty | Owned | Value | Receipt |
|---|---|---|---|---|---|---|---|---|---|
| 2026-05-29 | 2026-05-28 | BRYNJELSEN SEAN | Insider | sell | $32.67 | 148 | 833,694 | $5K | SEC Form 4 |
| 2026-05-29 | 2026-05-28 | BRYNJELSEN SEAN | Insider | sell | $31.88 | 119,852 | 833,842 | $3.8M | SEC Form 4 |
| 2026-05-27 | 2026-05-27 | Krempa David | Insider | sell | $31.47 | 19,679 | 25,249 | $619K | SEC Form 4 |
| 2026-05-27 | 2026-05-27 | Krempa David | Insider | buy | $3.58 | 7,203 | 44,928 | $26K | SEC Form 4 |
| 2026-05-27 | 2026-05-27 | Krempa David | Insider | buy | $1.37 | 12,476 | 37,725 | $17K | SEC Form 4 |
Showing 5 recent rows. Sovereign unlocks 20 additional rows, full sorting, and the named-filer history.
Upgrade to Sovereign · $25/moETON contract awards, year to date.
Public federal awards linked to this ticker.
ETON lobbying filings, year to date.
Registered lobbying filings matched to Eton Pharmaceuticals Inc.